2021
1. Simoens C, Gorbaslieva I, Gheit T, Holzinger D, et al. HPV-AHEAD study group. HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study. Cancer Epidemiol. 2021 Jun;72:101925. PMID: 33839457
2020
2. Muwonge R, Basu P, Gheit T, Anantharaman D, et al, Indian HPV vaccine study group. Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study. PLoS One. 2020 Dec 29;15(12):e0244242. PMID: 33373380
3. Preti M, Rotondo JC, Holzinger D, Micheletti L, et al. Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women. Infect Agent Cancer. 2020;15:20. PMID: 32266002
4. Tagliabue M, Mena M, Maffini F, Gheit T, et al. The Hpv-Ahead Study Group. Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study. Cancers (Basel). 2020 Nov 29;12(12):3567. PMID: 33260360
2019
5. Basu P, Muwonge R, Bhatla N, Nene BM, et al. Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort study. Papillomavirus research (Amsterdam, Netherlands). 2019;7:75-81. PMID: 30711698
6. de Sanjosé S, Serrano B, Tous S, Alejo M, et al, and Head and Neck study groups. Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58. JNCI Cancer Spectr. 2019 Jan 7;2(4):pky045. PMID: 31360870
7. Mena M, Taberna M, Monfil L, Arbyn M, et al. Might Oral Human Papillomavirus (HPV) Infection in Healthy Individuals Explain Differences in HPV-Attributable Fractions in Oropharyngeal Cancer? A Systematic Review and Meta-analysis. J Infect Dis. 2019 Apr 19;219(10):1574-1585. PMID: 30590684.
8. Rollison DE, Viarisio D, Amorrortu RP, Gheit T, et al. An Emerging Issue in Oncogenic Virology: the Role of Beta Human Papillomavirus Types in the Development of Cutaneous Squamous Cell Carcinoma. J Virol. 2019;93(7). PMID: 30700603
9. Tommasino M. HPV and skin carcinogenesis. Papillomavirus Res. 2019;7:129-31. PMID: 30953864
2018
10. Abrahao R, Anantharaman D, Gaborieau V, Abedi-Ardekani B, et al. The influence of smoking, age and stage at diagnosis on the survival after larynx, hypopharynx and oral cavity cancers in Europe: The ARCAGE study. Int J Cancer. 2018;143(1):32-44. PMID: 29405297
11. Anantharaman D, Billot A, Waterboer T, Gheit T, et al. Predictors of oropharyngeal cancer survival in Europe. Oral Oncol. 2018;81:89-94. PMID: 29884419
12. Brancaccio RN, Robitaille A, Dutta S, Cuenin C, et al. Generation of a novel next-generation sequencing-based method for the isolation of new human papillomavirus types. Virology. 2018;520:1-10. PMID: 29747121
13. de Sanjose S, Serrano B, Tous S, Alejo M, et al. Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58. JNCI cancer spectrum. 2018;2(4):pky045. PMID: 31360870
14. Sankaranarayanan R, Joshi S, Muwonge R, Esmy PO, et al. Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study. Vaccine. 2018;36(32 Pt A):4783-91. PMID: 29551226
15. Ursu RG, Danciu M, Spiridon IA, Ridder R, et al. Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania. PloS one. 2018;13(6):e0199663. PMID: 29940024
2017
16. Anantharaman D, Abedi-Ardekani B, Beachler DC, Gheit T, et al. Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer. International journal of cancer. 2017;140(9):1968-75. PMID: 28108990
17. Gheit T, Dutta S, Oliver J, Robitaille A, et al. Isolation and characterization of a novel putative human polyomavirus. Virology. 2017;506:45-54. PMID: 28342387
18. Gheit T, Anantharaman D, Holzinger D, Alemany L, et al, HPV-AHEAD study group. Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India. Int J Cancer. 2017 Jul 1;141(1):143-151. PMID: 28369859
19. Hernandez-Vargas H, Gruffat H, Cros MP, Diederichs A, et al. Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines. Sci Rep. 2017;7(1):5852. PMID: 28724958
20. Mena M, Lloveras B, Tous S, Bogers J, et al, HPV-AHEAD study group. Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study. PLoS One. 2017 Oct 16;12(10):e0184520. PMID: 29036167
21. Prigge ES, Arbyn M, von Knebel-Doeberitz M, Reuschenbach M. Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas. Int J Cancer 2017; 140(5): 1186-98. PMID: 27859245
22. Tommasino M. The biology of beta human papillomaviruses. Virus Res. 2017;231:128-38. PMID: 27856220
23. Viarisio D, Gissmann L, Tommasino M. Human papillomaviruses and carcinogenesis: well-established and novel models. Curr Opin Virol. 2017;26:56-62. PMID: 28778034
2016
24. Anantharaman D, Muller DC, Lagiou P, Ahrens W, et al. Combined effects of smoking and HPV16 in oropharyngeal cancer. Int J Epidemiol. 2016 Jun;45(3):752-61. PMID: 27197530
25. Arbyn M, Vanden Broeck D, Benoy I, Bogers J, et al. Surveillance of effects of HPV vaccination in Belgium. Cancer Epidemiol 2016; 41: 152-8. PMID: 26895623
26. Castellsagué X*, Alemany L*, Quer M, Halec G, et al, ICO International HPV in Head and Neck Cancer Study Group. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. J Natl Cancer Inst. 2016 Jan 28;108(6):djv403. PMID: 26823521.
27. D'Souza G, Anantharaman D, Gheit T, Abedi-Ardekani B, et al. Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents. Oral Oncol. 2016 Nov;62:20-27. PMID: 27865368
28. Giorgi-Rossi P, Ronco G, Dillner J, Elfström KM, et al. Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion. Cancer Cytopathol 2016; 124(1): 66-7. PMID: 26356132
29. Sabol I, Smahelova J, Klozar J, Mravak-Stipetic M, et al. Beta-HPV types in patients with head and neck pathology and in healthy subjects. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2016;82:159-65. PMID: 27500365
30. Sankaranarayanan R, Prabhu PR, Pawlita M, Gheit T, et al. Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study. The Lancet Oncology. 2016;17(1):67-77. PMID: 26652797
2015
31. Accardi R, Gruffat H, Sirand C, Fusil F, et al. The mycotoxin aflatoxin B1 stimulates Epstein-Barr virus-induced B-cell transformation in in vitro and in vivo experimental models. Carcinogenesis. 2015;36(11):1440-51. PMID: 26424750
32. Frecha C, Chevalier SA, van Uden P, Rubio I, et al. Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus. J Virol. 2015;89(2):1461-7. PMID: 25378492
33. Ghittoni R, Accardi R, Chiocca S, Tommasino M. Role of human papillomaviruses in carcinogenesis. Ecancermedicalscience. 2015;9:526. PMID: 25987895
34. Lang Kuhs KA, Anantharaman D, Waterboer T, Johansson M, et al. Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis. Cancer Epidemiol Biomarkers Prev. 2015 Apr;24(4):683-9. PMID: 25623733
35. Torres M, Gheit T, McKay-Chopin S, Rodriguez C, et al. Prevalence of beta and gamma human papillomaviruses in the anal canal of men who have sex with men is influenced by HIV status. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2015;67:47-51. PMID: 25959158
2014
36. Arbyn M, Tommasino M, Depuydt C, Dillner J. Are 20 human papillomavirus types causing cervical cancer? J Pathol. 2014;234(4):431-5. PMID: 25124771
37. Gillison ML, Castellsague X, Chaturvedi A, Goodman MT, et al. Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix. Int J Cancer 2014; 134(3): 497-507. PMID: 23568556
38. Ndiaye C, Mena M, Alemany L, Arbyn M, et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol 2014; 15(12): 1319-31. PMID: 25439690
39. Siouda M, Frecha C, Accardi R, Yue J, et al. Epstein-Barr virus down-regulates tumor suppressor DOK1 expression. PLoS Pathog. 2014;10(5):e1004125. PMID: 24809689
2013
40. Anantharaman D, Gheit T, Waterboer T, Abedi-Ardekani B, et al. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study. J Natl Cancer Inst. 2013 Apr 17;105(8):536-45. PMID: 23503618
41. Kreimer AR, Johansson M, Waterboer T, Kaaks R, et al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol. 2013 Jul 20;31(21):2708-15. PMID: 23775966
2012
42. Arbyn M, de Sanjose S, Saraiya M, Sideri M, et al. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer 2012; 131(9): 1969-82. PMID: 22623137
43. Bosch FX, Broker TR, Forman D, Moscicki AB, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine 2013; 31 Suppl 8: I1-I31. PMID: 24229716
44. Depuydt CE, Benoy IH, Beert JF, Criel AM, et al. Clinical validation of a type-specific real time quantitative human papillomavirus PCR to the performance of Hybrid Capture 2 for the purpose of cervical cancer screening. J Clin Microbiol 2012; 50(12): 4073-7. PMID: 23052314
45. Bray F, Lortet-Tieulent J, Znaor A, Brotons M, et al. Patterns and Trends in Human Papillomavirus-Related Diseases in Central and Eastern Europe and Central Asia. Vaccine 2013; 31 (Suppl 7): H32-H45. PMID: 24332296
46. Poljak M, Seme K, Maver PJ, Kocjan BJ, et al. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in central and eastern europe. Vaccine 2013; 31 Suppl 7: H59-H70. PMID: 24332297
47. Rogovskaya SI, Shabalova IP, Mikheeva IV, Minkina GN, et al. Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Russian Federation, the Western Countries of the former Soviet Union, Caucasus Region and Central Asia. Vaccine 2013; 31 Suppl 7: H46-H58. PMID: 24332297
2011
48. Arbyn M, Gissmann L, Schneider A, Kaufmann AM. Highlights of the 27th International Papillomavirus Conference and Clinical Workshop (Berlin, 17-22 September 2011) - Part I. Future Virol 2011; 6(12): 1389-96. https://doi.org/10.2217/fvl.11.126
49. Arbyn M, Schneider A, Gissmann L, Kaufmann AM. Highlights of the 27th International Papillomavirus Conference and Clinical Workshop (Berlin, 17-22 September 2011) - Part 2: Applied Clinical Science. Future Virol 2012; 7(1): 19-24. https://doi.org/10.2217/fvl.11.131
50. Arbyn M, Schneider A, Kaufmann AM, Gissmann L. Highlights of the 27th International Papillomavirus Conference and Clinical Workshop (Berlin, 17-22 September 2011) - Part 3: Epidemiology and Public Health. Future Virol 2012; 7(2): 127-33. https://doi.org/10.2217/fvl.11.147